"10.1371_journal.pone.0130340","plos one","2015-06-15T00:00:00Z","Niina M Santio; Sini K Eerola; Ilkka Paatero; Jari Yli-Kauhaluoma; Fabrice Anizon; Pascale Moreau; Johanna Tuomela; Pirkko Härkönen; Päivi J Koskinen","Section of Genetics and Physiology, Department of Biology, University of Turku, 20500 Turku, Finland; Drug Research Doctoral Programme, University of Turku, 20520 Turku, Finland; Institute of Biomedicine, Department of Medical Biochemistry and Genetics, University of Turku, 20520 Turku, Finland; Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, 00014 Helsinki, Finland; Institut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, Université Blaise Pascal, 63000 Clermont-Ferrand, France; Centre National de la Recherche Scientifique, 63178 Aubiere, France; Institute of Biomedicine, Department of Cell Biology and Anatomy, University of Turku, 20520 Turku, Finland; Pharmatest Services Ltd, 20520 Turku, Finland","Conceived and designed the experiments: PJK NMS PH. Performed the experiments: NMS SKE IP JT. Analyzed the data: NMS SKE IP JT PJK PH. Contributed reagents/materials/analysis tools: JYK FA PM. Wrote the paper: NMS PJK PH JT.","Johanna Tuomela was employed by Pharmatest Services Ltd for a period during the study. There are no patents, products in development, or marketed products to declare. This does not alter JT's adherence to all the PLOS ONE policies on sharing data and materials. Pirkko Härkönen is a PLOS ONE Editorial Board member, but this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","06","Niina M Santio","NMS",9,TRUE,3,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
